Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-23-022586
Filing Date
2023-05-16
Accepted
2023-05-16 19:55:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 14923
2 EX-24 sgen-ex24.htm EX-24 8582
  Complete submission text file 0000950170-23-022586.txt   24935
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Subject) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-32405 | Film No.: 23929329
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
ROMP CHARLES R (Reporting) CIK: 0001809717 (see all company filings)

Type: 144